Author:
Gomez Solsona Beatriz,Schmitt Anja,Schulze-Osthoff Klaus,Hailfinger Stephan
Abstract
Almost twenty years ago, the importance of the paracaspase MALT1 in antigen receptor-induced NF-κB activation was first described. Since then, several other immune receptors, G-protein-coupled receptors, and receptor tyrosine kinases were identified as relying on MALT1 to induce NF-κB activation. In various hematological malignancies and solid tumors, MALT1 is constitutively activated and drives chronic NF-κB target gene expression. Deregulated MALT1 activity in cancer thus promotes tumor cell survival, proliferation, and metastasis. Since the molecular function of MALT1 partially requires its protease activity, pharmacological targeting of MALT1 may represent a promising anti-cancer strategy. Here, we review the molecular features of MALT1 activation and function as well as the therapeutic potential of MALT1 inhibition in hematological malignancies and solid tumors.
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference107 articles.
1. NF-kappaB, Inflammation, Immunity and Cancer: Coming of Age;Nat. Rev. Immunol.,2018
2. NF-kappaB, an Active Player in Human Cancers;Cancer Immunol. Res.,2014
3. Unravelling the Complexities of the NF-KappaB Signalling Pathway Using Mouse Knockout and Transgenic Models;Oncogene,2006
4. Ramadass, V., Vaiyapuri, T., and Tergaonkar, V. (2020). Small Molecule NF-kappaB Pathway Inhibitors in Clinic. Int. J. Mol. Sci., 21.
5. CARD-BCL-10-MALT1 Signalling in Protective and Pathological Immunity;Nat. Rev. Immunol.,2019
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献